Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Sergi · SciRah

Researcher profile · Semantic Scholar

D. Sergi

Share profile

D. Sergi — researcher profile on SciRah

h-index: 25
Works: 109
Citations: 1,892

Most-cited papers

Triple positive breast cancer: a distinct subtype?
P. Vici, L. Pizzuti, C. Natoli, T. Gamucci +16 more
2015Cancer Treatment Reviews121 citations Open access
Semantic Scholar
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives
E. Krasniqi, G. Barchiesi, L. Pizzuti, M. Mazzotta +16 more
2019Journal of Hematology & Oncology114 citations Open access
Semantic Scholar
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies
P. Vici, L. Pizzuti, L. Mariani, G. Zampa +19 more
2016Expert Review of Vaccines100 citations Open access
Semantic Scholar
Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives
G. Barchiesi, M. Mazzotta, E. Krasniqi, L. Pizzuti +13 more
2020International Journal of Molecular Sciences70 citations Open access
Semantic Scholar
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience
P. Vici, L. Pizzuti, A. Michelotti, I. Sperduti +44 more
2017OncoTarget61 citations Open access
Semantic Scholar
Emerging Biological Treatments for Uterine Cervical Carcinoma
P. Vici, L. Mariani, L. Pizzuti, D. Sergi +10 more
2014Journal of Cancer57 citations Open access
Semantic Scholar
Vitamin D Supplementation and Breast Cancer Prevention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
F. Sperati, P. Vici, M. Maugeri-Saccà, S. Stranges +10 more
2013PLoS ONE57 citations Open access
Semantic Scholar
Laparoscopic Debulking Surgery in the Management of Advanced Ovarian Cancer After Neoadjuvant Chemotherapy
G. Corrado, E. Mancini, G. Cutillo, E. Baiocco +6 more
2015International Journal of Gynecologic Cancer46 citations Open access
Semantic Scholar
Immunologic treatments for precancerous lesions and uterine cervical cancer
P. Vici, L. Mariani, L. Pizzuti, D. Sergi +7 more
2014Journal of experimental & clinical cancer research : CR46 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy in triple‐negative breast cancer: A multicentric retrospective observational study in real‐life setting
T. Gamucci, L. Pizzuti, I. Sperduti, L. Mentuccia +26 more
2018Journal of Cellular Physiology45 citations
Semantic Scholar
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study
P. Vici, L. Pizzuti, C. Natoli, L. Moscetti +20 more
2014Breast Cancer Research and Treatment42 citations Open access
Semantic Scholar
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study
T. Gamucci, L. Pizzuti, C. Natoli, L. Mentuccia +45 more
2018Cancer Biology & Therapy40 citations Open access
Semantic Scholar
“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome
P. Vici, L. Pizzuti, I. Sperduti, A. Frassoldati +29 more
2016OncoTarget39 citations Open access
Semantic Scholar
The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy
P. Vici, M. Mottolese, L. Pizzuti, M. Barba +14 more
2014OncoTarget38 citations Open access
Semantic Scholar
Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment
S. Buglioni, P. Vici, D. Sergi, L. Pizzuti +18 more
2016Oncoimmunology36 citations Open access
Semantic Scholar
FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort
M. Maugeri-Saccà, L. Pizzuti, D. Sergi, M. Barba +7 more
2013Journal of experimental & clinical cancer research : CR36 citations Open access
Semantic Scholar
Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future Perspectives
E. Krasniqi, M. Barba, A. Venuti, L. Pizzuti +21 more
2021Journal of Clinical Medicine34 citations Open access
Semantic Scholar
Laparoscopic versus robotic radical hysterectomy after neoadjuvant chemotherapy in locally advanced cervical cancer: a case control study.
E. Vizza, G. Corrado, E. Mancini, P. Vici +6 more
2015European Journal of Surgical Oncology34 citations
Semantic Scholar
Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis
L. di Lauro, L. Pizzuti, M. Barba, D. Sergi +9 more
2015Journal of Hematology & Oncology34 citations Open access
Semantic Scholar
Surgical and Oncological Outcome of Robotic Surgery Compared With Laparoscopic and Abdominal Surgery in the Management of Locally Advanced Cervical Cancer After Neoadjuvant Chemotherapy
G. Corrado, G. Cutillo, M. Saltari, E. Mancini +8 more
2015International Journal of Gynecologic Cancer30 citations Open access
Semantic Scholar
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first‐line chemotherapy
L. Ronchetti, E. Melucci, F. de Nicola, F. Goeman +19 more
2017International Journal of Cancer29 citations Open access
Semantic Scholar
Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer
L. di Lauro, P. Vici, P. del Medico, L. Laudadio +6 more
2013Breast Cancer Research and Treatment29 citations
Semantic Scholar
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real‐world evidence
E. Krasniqi, L. Pizzuti, Giacomo Barchiesi, D. Sergi +64 more
2020Journal of Cellular Physiology27 citations
Semantic Scholar
Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer
L. di Lauro, P. Vici, F. Belli, S. Tomao +8 more
2014Gastric Cancer26 citations Open access
Semantic Scholar
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study
P. Vici, G. Colucci, F. Giotta, D. Sergi +10 more
2011Journal of experimental & clinical cancer research : CR25 citations Open access
Semantic Scholar
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: A real‐world experience
L. Pizzuti, A. Giordano, A. Michelotti, M. Mazzotta +64 more
2018Journal of Cellular Physiology24 citations Open access
Semantic Scholar
Androgen receptor and antiandrogen therapy in male breast cancer.
L. di Lauro, M. Barba, L. Pizzuti, P. Vici +7 more
2015Cancer Letters23 citations Open access
Semantic Scholar
Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting
C. Mandoj, L. Pizzuti, D. Sergi, I. Sperduti +18 more
2018Journal of Translational Medicine22 citations Open access
Semantic Scholar
Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis
R. Grande, C. Natoli, F. Ciancola, D. Gemma +16 more
2016PLoS ONE22 citations Open access
Semantic Scholar
The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression
S. Buglioni, E. Melucci, F. Sperati, Matteo Pallocca +19 more
2018Oncoimmunology21 citations Open access
Semantic Scholar
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer
L. Pizzuti, D. Sergi, C. Mandoj, B. Antoniani +19 more
2018Journal of Cellular Physiology21 citations Open access
Semantic Scholar
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study
E. Krasniqi, A. Sacconi, D. Marinelli, L. Pizzuti +20 more
2021Biomarker Research20 citations Open access
Semantic Scholar
Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series
L. di Lauro, P. Vici, M. Barba, L. Pizzuti +9 more
2014Breast Cancer Research and Treatment20 citations
Semantic Scholar
Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma
L. di Lauro, L. Giacinti, M. Arena, D. Sergi +3 more
2009Journal of experimental & clinical cancer research : CR20 citations Open access
Semantic Scholar
Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy
Cristiana Ercolani, A. di Benedetto, I. Terrenato, L. Pizzuti +14 more
2017Cancer Biology & Therapy19 citations Open access
Semantic Scholar
Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study
L. di Lauro, L. Pizzuti, M. Barba, D. Sergi +7 more
2015Journal of experimental & clinical cancer research : CR19 citations Open access
Semantic Scholar
Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis
P. Vici, A. di Benedetto, Cristiana Ercolani, L. Pizzuti +18 more
2015OncoTarget19 citations Open access
Semantic Scholar
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial
L. Pizzuti, M. Barba, M. Mazzotta, E. Krasniqi +52 more
2021Scientific Reports18 citations Open access
Semantic Scholar
A Real‐World Multicentre Retrospective Study of Paclitaxel‐Bevacizumab and Maintenance Therapy as First‐Line for HER2‐Negative Metastatic Breast Cancer
T. Gamucci, L. Mentuccia, C. Natoli, I. Sperduti +27 more
2016Journal of Cellular Physiology18 citations Open access
Semantic Scholar
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study
L. Pizzuti, P. Marchetti, C. Natoli, T. Gamucci +21 more
2017Scientific Reports17 citations Open access
Semantic Scholar
Metformin and breast cancer: basic knowledge in clinical context.
L. Pizzuti, P. Vici, L. di Lauro, D. Sergi +5 more
2015Cancer Treatment Reviews17 citations
Semantic Scholar
Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations
M. Maugeri-Saccà, M. Barba, P. Vici, L. Pizzuti +3 more
2014Breast Cancer Research and Treatment17 citations
Semantic Scholar
Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients
P. Vici, D. Sergi, L. Pizzuti, L. Mariani +11 more
2013Journal of experimental & clinical cancer research : CR16 citations Open access
Semantic Scholar
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
E. Melucci, B. Casini, L. Ronchetti, L. Pizzuti +20 more
2018Journal of Translational Medicine15 citations Open access
Semantic Scholar
DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis
P. Vici, S. Buglioni, D. Sergi, L. Pizzuti +18 more
2016PLoS ONE15 citations Open access
Semantic Scholar
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin
M. Barba, L. Pizzuti, I. Sperduti, C. Natoli +18 more
2016Journal of Cellular Physiology15 citations
Semantic Scholar
Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Epithelial Ovarian Cancer: A 20-Year Single-Center Experience
F. Carboni, O. Federici, I. Sperduti, S. Zazza +3 more
2021Cancers14 citations Open access
Semantic Scholar
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab
L. Pizzuti, D. Sergi, I. Sperduti, L. di Lauro +29 more
2018Cancer Biology & Therapy14 citations Open access
Semantic Scholar
Anthropometric, clinical and molecular determinants of treatment outcomes in postmenopausal, hormone receptor positive metastatic breast cancer patients treated with fulvestrant: Results from a real word setting
L. Pizzuti, C. Natoli, T. Gamucci, Mariella Mauri +12 more
2017OncoTarget14 citations Open access
Semantic Scholar
Cancer mortality trends between 1988 and 2009 in the metropolitan area of Naples and Caserta, Southern Italy
A. Crispo, M. Barba, M. Malvezzi, G. Arpino +7 more
2013Cancer Biology & Therapy14 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Vici×46
Invite
P. Vici — researcher profile on SciRah
L. Pizzuti×43
Invite
L. Pizzuti — researcher profile on SciRah
M. Barba×42
Invite
M. Barba — researcher profile on SciRah
L. di Lauro×38
Invite
L. di Lauro — researcher profile on SciRah

M. Maugeri-Saccà

×37

Invite

M. Maugeri-Saccà — researcher profile on SciRah

Invite

T. Gamucci — researcher profile on SciRah

Invite

C. Natoli — researcher profile on SciRah

P. Marchetti×20

Invite

P. Marchetti — researcher profile on SciRah

I. Sperduti×19

Invite

I. Sperduti — researcher profile on SciRah

R. De Maria×19

Invite

R. De Maria — researcher profile on SciRah

Invite

S. Tomao — researcher profile on SciRah

A. Giordano×15

Invite

A. Giordano — researcher profile on SciRah